✦ LIBER ✦

Rationale and design of a phase II clinical trial of aspirin and simvastatin for the treatment of pulmonary arterial hypertension: ASA-STAT

✍ Scribed by Steven M. Kawut; Emilia Bagiella; Daichi Shimbo; David J. Lederer; Nadine Al-Naamani; Kari E. Roberts; R. Graham Barr; Wendy Post; Evelyn M. Horn; Russell Tracy; Paul Hassoun; Reda Girgis

Book ID: 116350972
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 297 KB
Volume: 32
Category: Article
ISSN: 1551-7144
DOI: 10.1016/j.cct.2010.12.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast ductal lavage for biomarker asses

Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo

✍ Matteo Lazzeroni, Aliana Guerrieri-Gonzaga, Davide Serrano, Massimiliano Cazzani 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 623 KB

CHAMPION Trial Rationale and Design: The

CHAMPION Trial Rationale and Design: The Long-Term Safety and Clinical Efficacy of a Wireless Pulmonary Artery Pressure Monitoring System

✍ Philip B. Adamson; William T. Abraham; Mark Aaron; Juan M. Aranda Jr.; Robert C. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 357 KB

The Reconditioning Exercise and Chronic

The Reconditioning Exercise and Chronic Obstructive Pulmonary Disease Trial II (REACT II): Rationale and study design for a clinical trial of physical activity among individuals with chronic obstructive pulmonary disease

✍ Capri G. Foy; Katie L. Wickley; Norman Adair; Wei Lang; Michael E. Miller; W. Ja 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Rationale and design of the AngeLmed for

Rationale and design of the AngeLmed for Early Recognition and Treatment of STEMI trial: A randomized, prospective clinical investigation

✍ Gibson, Michael C.; Krucoff, Mitchell; Fischell, David; Fischell, Tim A.; Keenan 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 334 KB

Imatinib in combination with cytarabine

Imatinib in combination with cytarabine for the treatment of Philadelphia-positive chronic myelogenous leukemia chronic-phase patients: Rationale and design of phase I/II trials

✍ François Guilhot; Martine Gardembas; Philippe Rousselot; Michel Tulliez; Magda V 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 82 KB

The Second Prevention of Syncope Trial (

The Second Prevention of Syncope Trial (POST II)—a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: Rationale and study design

✍ Satish R. Raj; Sarah Rose; Deborah Ritchie; Robert S. Sheldon 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 144 KB